{"context":{"query":">>mondo>>clinical_trials","source_dataset":"mondo","target_dataset":"clinical_trials"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0010108,73,MONDO:0010108,38,0]["},"schema":"id|brief_title|overall_status|phase|study_type","mappings":[{"input":"MONDO:0010108","source":"MONDO:0010108|testicular germ cell tumor","targets":["NCT00050635|STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea|COMPLETED|PHASE4|INTERVENTIONAL","NCT00117039|A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia|COMPLETED|PHASE4|INTERVENTIONAL","NCT00216541|A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00230217|Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy|COMPLETED|PHASE4|INTERVENTIONAL","NCT00630084|Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma|COMPLETED|PHASE4|INTERVENTIONAL","NCT00684463|Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00687011|Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)|COMPLETED|PHASE4|INTERVENTIONAL","NCT00894153|p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01107756|A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen|COMPLETED|PHASE4|INTERVENTIONAL","NCT01394991|A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia|COMPLETED|PHASE4|INTERVENTIONAL","NCT01427400|The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01471756|Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia|COMPLETED|PHASE4|INTERVENTIONAL","NCT01481831|Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting|COMPLETED|PHASE4|INTERVENTIONAL","NCT01588184|An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT01739764|An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol|COMPLETED|PHASE4|INTERVENTIONAL","NCT01789281|Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.|COMPLETED|PHASE4|INTERVENTIONAL","NCT01802996|Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury|UNKNOWN|PHASE4|INTERVENTIONAL","NCT01862198|The Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent|COMPLETED|PHASE4|INTERVENTIONAL","NCT02532634|Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone|COMPLETED|PHASE4|INTERVENTIONAL","NCT02581176|Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT03333655|Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy|COMPLETED|PHASE4|INTERVENTIONAL","NCT03895502|Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study|COMPLETED|PHASE4|INTERVENTIONAL","NCT04724460|Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer|COMPLETED|PHASE4|INTERVENTIONAL","NCT05440240|Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture|RECRUITING|PHASE4|INTERVENTIONAL","NCT06005259|Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)|UNKNOWN|PHASE4|INTERVENTIONAL","NCT06706921|18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer|RECRUITING|PHASE4|INTERVENTIONAL","NCT00002566|Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors|COMPLETED|PHASE3|INTERVENTIONAL","NCT00002596|Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003014|Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00003643|Combination Chemotherapy in Treating Men With Germ Cell Cancer|UNKNOWN|PHASE2/PHASE3|INTERVENTIONAL","NCT00003941|Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00004219|Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00005590|Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma|COMPLETED|PHASE3|INTERVENTIONAL","NCT00037791|Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00038064|Anemia in Patients With a Non-Myeloid Malignancy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00072215|Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors|TERMINATED|PHASE3|INTERVENTIONAL","NCT00104676|Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors|COMPLETED|PHASE3|INTERVENTIONAL","NCT00124930|Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00125801|The Pain Pen for Breakthrough Cancer Pain|TERMINATED|PHASE3|INTERVENTIONAL","NCT00169845|Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients|COMPLETED|PHASE3|INTERVENTIONAL","NCT00194493|Computerized Assessment for Patients With Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00210587|An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation|COMPLETED|PHASE3|INTERVENTIONAL","NCT00273741|Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients|TERMINATED|PHASE3|INTERVENTIONAL","NCT00302185|Acupuncture in Palliative Cancer Care|COMPLETED|PHASE3|INTERVENTIONAL","NCT00324298|Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles|COMPLETED|PHASE3|INTERVENTIONAL","NCT00324324|Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant|TERMINATED|PHASE3|INTERVENTIONAL","NCT00350090|A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.|TERMINATED|PHASE3|INTERVENTIONAL","NCT00384891|Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT00417079|XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT00589537|Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle|UNKNOWN|PHASE3|INTERVENTIONAL","NCT00625378|Sorafenib Long Term Extension Program|COMPLETED|PHASE3|INTERVENTIONAL","NCT00735813|Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00766233|Optimal Application Dose of Superficial Hyperthermia|COMPLETED|PHASE3|INTERVENTIONAL","NCT00822809|CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers|COMPLETED|PHASE3|INTERVENTIONAL","NCT00830778|Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy|COMPLETED|PHASE3|INTERVENTIONAL","NCT00838201|Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01009593|Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)|TERMINATED|PHASE3|INTERVENTIONAL","NCT01086683|Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01087268|Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01164046|Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism|TERMINATED|PHASE3|INTERVENTIONAL","NCT01180751|18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01214343|Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01233713|Hartmann's Versus Primary Anastomosis in Left-sided Colon Perforation|COMPLETED|PHASE2/PHASE3|INTERVENTIONAL","NCT01309386|A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants|COMPLETED|PHASE3|INTERVENTIONAL","NCT01403779|Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT01591746|Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction|COMPLETED|PHASE3|INTERVENTIONAL","NCT01655927|Efficacy of Tranexamic Acid in Brain Tumor Resections|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01657955|Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia|UNKNOWN|PHASE3|INTERVENTIONAL","NCT01964378|CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer|TERMINATED|PHASE3|INTERVENTIONAL","NCT01964430|Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the Apact Study)|COMPLETED|PHASE3|INTERVENTIONAL","NCT02031432|CORAL XT - Open-label Extension Trial of the CORAL Trial|COMPLETED|PHASE3|INTERVENTIONAL","NCT02155634|Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT02203253|Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting|COMPLETED|PHASE3|INTERVENTIONAL","NCT02254915|SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I|WITHDRAWN|PHASE3|INTERVENTIONAL","NCT02330926|Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy|COMPLETED|PHASE3|INTERVENTIONAL","NCT02341989|Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT02375204|Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT02526953|Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients|UNKNOWN|PHASE3|INTERVENTIONAL","NCT02548715|Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery|WITHDRAWN|PHASE2/PHASE3|INTERVENTIONAL","NCT02555878|A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants|COMPLETED|PHASE3|INTERVENTIONAL","NCT02721641|A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer|COMPLETED|PHASE3|INTERVENTIONAL","NCT02944045|Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03194893|A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT03402048|The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03435796|Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells|RECRUITING|PHASE2/PHASE3|INTERVENTIONAL","NCT03495921|A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide|TERMINATED|PHASE3|INTERVENTIONAL","NCT03721341|Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT03889626|The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer|UNKNOWN|PHASE3|INTERVENTIONAL","NCT03961841|Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ Adenocarcinoma|NOT_YET_RECRUITING|PHASE3|INTERVENTIONAL","NCT03981796|A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT04222972|A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)|COMPLETED|PHASE3|INTERVENTIONAL","NCT04607421|A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT04711109|Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT04763135|Mirtazapine in Cancer-related Poly-symptomatology|TERMINATED|PHASE3|INTERVENTIONAL","NCT05112965|An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05417789|Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)|ACTIVE_NOT_RECRUITING|PHASE3|INTERVENTIONAL","NCT05704894|Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens|UNKNOWN|PHASE3|INTERVENTIONAL","NCT06496971|A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients|RECRUITING|PHASE3|INTERVENTIONAL","NCT00000603|Cord Blood Stem Cell Transplantation Study (COBLT)|COMPLETED|PHASE2|INTERVENTIONAL","NCT00001189|The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors|COMPLETED|PHASE2|INTERVENTIONAL"]}]}